LWCFA
NUVA

Loring Wolcott & Coolidge Fiduciary Advisors’s NuVasive, Inc. NUVA Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12
Closed – – 899
2017
Q3 		$0 Buy
+12
New +$794 ﹤0.01% 925

Other funds holding NUVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's NUVA Position: Q4 2017 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of NuVasive, Inc. (NUVA) in Q4 2017, closing a stake of 12 shares.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in NUVA in Q3 2017 and held it in 1 quarter. The position peaked at $0 in Q3 2017. 269 funds tracked by Wall St. Rank hold NUVA as of Q4 2017.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining NuVasive, Inc. position as of Q4 2017 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 12 NuVasive, Inc. shares in Q4 2017.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in NuVasive, Inc. in Q3 2017 and held it in 1 quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors's NuVasive, Inc. position peaked at $0 in Q3 2017.
  • 269 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2017.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2017, filed 8 Feb 2018.